A Biotech Pullback Could be Afoot

The healthcare sector has been hot for most of this year and biotechnology stocks are a big reason why, but the iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotech ETF by assets, is off by 5% over the past month. “The top 3 IBB holdings are Biogen (NASDAQ: BIIB), Amgen,...